0001179110-15-012247.txt : 20150817
0001179110-15-012247.hdr.sgml : 20150817
20150817192134
ACCESSION NUMBER: 0001179110-15-012247
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150813
FILED AS OF DATE: 20150817
DATE AS OF CHANGE: 20150817
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theravance Biopharma, Inc.
CENTRAL INDEX KEY: 0001583107
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
BUSINESS PHONE: 650-808-6000
MAIL ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GALA RENEE D
CENTRAL INDEX KEY: 0001607737
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36033
FILM NUMBER: 151059927
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgar.xml
FORM 4 -
X0306
4
2015-08-13
0
0001583107
Theravance Biopharma, Inc.
TBPH
0001607737
GALA RENEE D
C/O THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BLVD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
SVP, Chief Financial Officer
Ordinary Shares
2015-08-13
4
P
0
5000
12.19
A
154279
D
Ordinary Shares
2015-08-17
4
P
0
5000
12.16
A
161177
D
Represents the weighted average purchase price per share for the open market purchase on August 13, 2015. The shares were purchased at prices ranging from $12.18 to $12.20 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average purchase price per share for the open market purchase on August 17, 2015. The shares were purchased at prices ranging from $12.12 to $12.24 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Includes 1,898 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2015.
Renee D. Gala
2015-08-17